Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.
about
Nicotine ameliorates schizophrenia-like cognitive deficits induced by maternal LPS exposure: a study in rats.Deletion of striatal adenosine A(2A) receptor spares latent inhibition and prepulse inhibition but impairs active avoidance learningLearned irrelevance and associative learning is attenuated in individuals at risk for psychosis but not in asymptomatic first-degree relatives of schizophrenia patients: translational state markers of psychosis?Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.Contribution of nonprimate animal models in understanding the etiology of schizophrenia.Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?Assessing the construct validity of aberrant salienceScopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.Latent inhibition-related dopaminergic responses in the nucleus accumbens are disrupted following neonatal transient inactivation of the ventral subiculum.Peripherally administered oxytocin modulates latent inhibition in a manner consistent with antipsychotic drugsEarly prefrontal functional blockade in rats results in schizophrenia-related anomalies in behavior and dopamineCholinergic connectivity: it's implications for psychiatric disorders.Are persistent delusions in schizophrenia associated with aberrant salience?Error correction in latent inhibition and its disruption by opioid receptor blockade with naloxone.Can the role of genetic factors in schizophrenia be enlightened by studies of candidate gene mutant mice behaviour?The positive symptoms of acute schizophrenia and latent inhibition in humans and animals: underpinned by the same process(es)?Accounting for individual differences in human associative learning.Memory reconsolidation in aversive and appetitive settings.Consequences at adulthood of transient inactivation of the parahippocampal and prefrontal regions during early development: new insights from a disconnection animal model for schizophreniaDisrupted latent inhibition in individuals at ultra high-risk for developing psychosis.Impaired Latent Inhibition in GDNF-Deficient Mice Exposed to Chronic Stress.Prefrontal cortical GABA transmission modulates discrimination and latent inhibition of conditioned fear: relevance for schizophreniaThe differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers.Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia.Decreased amphetamine-induced locomotion and improved latent inhibition in mice mutant for the M5 muscarinic receptor gene found in the human 15q schizophrenia region.Expression of the CS- and US-pre-exposure effects in the conditioned taste aversion paradigm and their abolition following systemic amphetamine treatment in C57BL6/J mice.Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers.Latent inhibition and asymmetrical visual-spatial attention in children with ADHD.Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers.Postweaning isolation affects responses to incentive contrast in adulthood.Intravenous administration of haloperidol to healthy volunteers: lack of subjective effects but clear objective effects.Schizophrenia and Substance Abuse Co-Morbidity
P2860
Q30371377-87D39F57-D52D-44FE-ADA2-32CF27102F21Q30440698-079F9B9C-E9CC-4233-8447-0FA67DDAA01DQ30464314-A331539C-8ED9-4880-A5D3-41A46D7C49C1Q30474007-F3ED747F-5DD0-4EA3-B1D8-138E8F257318Q30474963-518D31FD-A03B-4DCA-9409-0FC2C31B2B00Q30475350-9BF0CE2F-3DB8-49FE-AFAE-AA38BC7FD96DQ33575242-9D97D5F5-D2F8-49D4-8A92-5FABF675840FQ33999521-6C778ECE-0198-4A20-9EE1-51D83F3D0BAAQ34988421-8438AB0D-2A5C-429B-86B3-B7E500874A7BQ35243257-14D63DDA-A896-41E5-A60F-2D0454E44041Q36174072-BBE7DCBD-A442-4E3E-B770-398F7E0F8F0DQ36812599-87E13B16-C36D-4F94-A18D-335A8370023DQ36946136-9212A37A-6B9F-47BE-A08C-B54D7343B8F6Q37235822-248E01F5-0B01-40D6-93FF-1422C6B79D9DQ37461063-C26B6F86-02DC-4A4D-9598-25386609986BQ37996421-43B65F6A-3B0A-4101-91D7-B7621A2E19DFQ38136648-29554365-1E8A-446C-A95F-4D566C4F8966Q38140857-1CE23B22-9663-40FF-8D59-E6A6DD9614FAQ38207989-F3940FD9-5228-472F-8C20-7B92A0B4C05BQ41040167-1AFDAFD0-8875-420A-892D-EFC55CEC63FAQ42654189-11CE33B3-ED67-4BF7-B0AE-7AAFD0DF189AQ42819887-768A2372-0687-4BC3-9A47-D41BD95A4900Q43670042-069B14BC-F0DB-48F1-80BB-64FB7613A29CQ44357525-AD508594-E835-4D22-B8F1-AFC6CF6BAA5AQ44515032-09751736-6B24-4D17-81FC-CAC1C4706157Q44949323-2F2D564C-223F-4F6E-9583-4DF889D9F413Q44967609-3FDEB286-EBEB-4AF6-BDAA-88A26F4136B9Q44983978-6CEF4E06-8FB1-451F-8B0E-4BCB1DB381E7Q46818275-721538B6-7E15-448C-945C-5BF585DD4C34Q47621751-98CF27B7-6BA9-4B93-8449-8C7BE1B9AA65Q50606311-E6AC32EC-E5B2-495C-B23E-9C008638079FQ51107399-1D989BD3-329D-48FB-A729-F677988597DBQ57403357-AB51E252-F846-4B78-BA16-69200A7622C4
P2860
Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Latent inhibition in drug naiv ...... opamine D2 binding using SPET.
@en
Latent inhibition in drug naiv ...... opamine D2 binding using SPET.
@nl
type
label
Latent inhibition in drug naiv ...... opamine D2 binding using SPET.
@en
Latent inhibition in drug naiv ...... opamine D2 binding using SPET.
@nl
prefLabel
Latent inhibition in drug naiv ...... opamine D2 binding using SPET.
@en
Latent inhibition in drug naiv ...... opamine D2 binding using SPET.
@nl
P2093
P1476
Latent inhibition in drug naiv ...... opamine D2 binding using SPET.
@en
P2093
P304
P356
10.1016/0920-9964(95)00034-J
P407
P577
1995-09-01T00:00:00Z